Deutsche Bank Aktiengesellschaft »

Peregrine Pharmaceuticals shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $641k 99k 6.50
2023-09-30 $320k 34k 9.44
2023-06-30 $419k 30k 13.97
2023-03-31 $2.1M 112k 18.76
2022-12-31 $458k 33k 13.77
2022-09-30 $551k 29k 19.03
2022-06-30 $541k 36k 15.27
2022-03-31 $756k 38k 20.12
2021-12-31 $1.2M 41k 29.18
2021-09-30 $859k 40k 21.67
2021-06-30 $1.5M 61k 25.48
2021-03-31 $1.1M 59k 18.10
2020-12-31 $592k 52k 11.38
2020-09-30 $278k 36k 7.76
2020-06-30 $177k 28k 6.33
2020-03-31 $137k 27k 5.13
2019-12-31 $486k 64k 7.60
2019-09-30 $83k 16k 5.07
2019-06-30 $0 44k 0.00
2019-03-31 $0 91k 0.00
2018-12-31 $715k 175k 4.09
2018-09-30 $853k 116k 7.37
2018-06-30 $0 81k 0.00
2018-03-31 $44k 15k 2.90